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Abstract 
We have recently shown that differentiating bone 
cells are capable of elaborating, in vitro, a calcified ma-
trix at the interface with several non-biological substrata 
which is similar to cement lines found in remodelling 
bone tissue. From previous morphological observations, 
this matrix appeared free of assembled collagen fibres 
which indicated that osteogenic cells produce an initial 
mineralized matrix before overt collagen fibre produc-
tion. In the work reported herein, we used six anti-
bodies to extracellular matrix components and two con-
jugates of secondary antibody, fluorescein and colloidal 
gold, to initiate a preliminary characterization of the 
organic components at the bone cell substratum interface 
at early periods of culture. The labels were visualized 
by transmitted fluorescence light and immuno-gold scan-
ning electron microscopy, respectively. Both secondary 
and backscattered modes were employed in the latter . 
The results showed that while chondroitin sul-
phate was ubiquitous in this culture system, osteopontin 
labeled discretely at the ends of cell pseudopodia, initial-
ly, following which the substratum surface was strongly 
labeled. The distribution of fibronectin was significantly 
different to that of osteopontin and indicated that this 
protein was primarily involved in cell/cell rather than 
cell/substratum adhesion. Although Type I collagen was 
not present in the extracellular matrix at early periods of 
culture, it was evident intracellularly at 3 days and ex-
tracellularly after the formation of the initial cement-like 
matrix. However, Type III collagen displayed the in-
verse sequence. In less mature cultures, it exhibited a 
ubiquitous distribution, while it was un-detectable at 
later stages of culture. Finally, osteocalcin was the only 
antibody employed which showed no labeling at early 
culture periods while at later stages, both the cellular 
compartment and the previously formed interfacial 
matrix labeled positively. 
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Introduction 
The formation of bone depends upon the metabol-
ic and secretory activities of only one cell type: the 
osteoblast. While this statement emphasizes the activity 
of phenotypically mature osteoblasts, it does not negate 
the importance of the cascade of biological phenomena 
which comprise osteogenic cell maturation. When os-
teogenic cells reach the site of imminent bone tissue 
elaboration, matrix secretion events which precede ex-
pression of the mature osteoblastic phenotype may be of 
critical importance not only in the elaboration of the 
bone proper but also in influencing the further differenti-
ation of the osteogenic cells , as is seen with other hard 
tissue matrices (Magloire et al. , 1992; Thesleff and 
Vaahtokari, 1992). Indeed, at remodelling bony sites, 
two distinct matrix formation events occur before the 
onset of collagen mineralization. First: a cement line, 
comprising a mineralized but collagen free matrix, acts 
as the interfacial layer between old and new bone pro-
per. Second: the latter is elaborated as an unmineralized 
collagenous matrix, osteoid, which after a further delay 
becomes calcified. Although little is known concerning 
early matrix synthesis by differentiating bone cells, os-
teoblast differentiation is, currently, considered to be ac-
companied by the expression of several non-collagenous 
bone proteins prior to the onset of both collagen assem-
bly and mineralization (Stein et al., 1990; Lian and 
Stein, 1992). Clearly, the implications of unravelling 
this cascade of bone cell secretory activity is of impor-
tance not only in understanding bone tissue metabolism 
but also the nature of the interface which may be estab-
lished between bone tissue and artificial materials. 
To avoid the complexity of the in vivo environ-
ment, we have used an in vitro method to investigate the 
earliest matrix elaboration , by rat bone marrow derived 
differentiating osteogenic cells which have been reported 
to elaborate high yields of morphologically and biochem-
ically identifiable bone matrix in short experimental pe-
riods (Maniatopoulos et al., 1988). These in vitro expe-
riments have demonstrated that the initial matrix elab-
orated by differentiating osteogenic cells is analogous to 
the cement line, found in vivo, which forms the natural 
interface between old and new bone (Davies et al., 
X. Shen, E. Roberts, S.A.F. Peel and J .E. Davies 
199la). Indeed , we have recently shown that the glob-
ular mineralized matrix, approximately half a microm-
eter thick, which comprises this interfacial layer can also 
be morphologically identified in natural bone tissue at 
remodeling sites (Zhou et al., 1993). This in vitro 
approach, and its critical dependence upon the presence 
of differentiating cells at the interface with the culture 
substratum, has provided not only new information on 
the formation of bone on natural and foreign surfaces, 
but also a re-interpretation of ultrastructural descriptions 
of bone biomaterial interfaces pre.viously available iil the 
literature (Davies et al., 1991b,c; Lowenberg et al., 
1991 ; Pilliar et al., 1991). Specifically, since the 
cement line structure comprises a layer of individual 
globular accretions , we postulated that an organic 
matrix, secreted by the differentiating bone cells, must 
play an important role in the initial cement line mineral-
ization events (Davies et al., 1991a) . 
In the work reported herein , we used six antibod-
ies to extracellular matrix components and two conju-
gates of secondary antibody , fluorescein and colloidal 
gold, to initiate a preliminary characterization of the 
organic components at the bone cell substratum interface 
at early periods of culture. The labels were visualized 
by transmitted fluorescence light and immuno-gold scan-
ning electron microscopy (immuno-SEM) respectively. 
Materials and Methods 
Cell harvesting and culture 
Rat bone marrow (RBM) cells were obtained from 
young adult male Wistar rats (approximately 120 gm) ac-
cording to the method described previously (Davies et 
al. , 199lb). Briefly, for primary cultures, femora were 
removed and washed with a-minimal essential medium 
(a-MEM) containing 1.0 mg/ml penicillin G, 0.5 mg/ml 
gentamicin and 3.0 µg/ml fungizone . The epiphyses 
were removed and the marrow washed out using a-MEM 
supplemented with 15% fetal bovine serum, 50 µg/ml of 
freshly-prepared ascorbic acid [added as 1 % of a 
5 mg/ml stock solution in phosphate buffered saline 
(PBS)], 10 mM Na 13-glycerophosphate (added as l % of 
a 1 M stock solution in double distilled water) and anti-
biotics at l/ lOth of the concentration described above. 
This medium was further supplemented with 10-8 M dex-
amethasone (DEX). The specific concentrations of these 
culture medium additions employed were those reported 
by Maniatopoulos et al. (1988) . 
Aliquots of the RBM cell suspension , at a cell 
density of 0.4 x 105 cells/coverslip, were cultured on 
22 mm square glass coverslips, maintained in a humidi-
fied atmosphere of 95% air with 5 % C02. The medium, 
containing 10-8 M DEX, was changed after the first 24 
hours to remove non-adherent cells. The cultures and 
the medium was renewed up to three times. These cul-
tures were maintained from 3 to 12 days and then pre-
pared for fluorescence microscopy. 
Other primary cultures, prepared as described 
above but in T75 tissue culture flasks (Falcon) were 
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passaged at Day 5 at 105 cells/ml into 35 mm dishes 
(1 ml/dish) . These sub-cultures were maintained for 11 
days in identical conditions to those described above and 
processed for immuno-SEM. 
Primary and secondary antibodies 
Six antibodies were included in the present study: 
(i) CS-56 mouse monoclonal anti-chicken chondroitin 
sulphate [Sigma Immuno Chemicals, St. Louis , MO; 
working dilution (wd) 1:200] which has been shown to 
react with chondroitin sulfates of types A and ·c (not 
with type B) but shows no species or cell specificity 
(Abnur and Geiger, 1984; 1985; Takeuchi et al., 1990) ; 
(ii) affinity purified goat polyclonal anti-human (and 
bovine) Type III collagen (Southern Biotechnology Asso-
ciates, Inc. , Birmingham, AL; wd 1 :200) which reacts 
with type III collagen from most other species; (iii) 
mouse monoclonal anti-rat osteopontin (University of 
Iowa Hybridoma Bank, Iowa City, IA; wd 1:800) ; (iv) 
goat polyclonal anti-rat osteocalcin (Biomedical Technol-
ogies Inc., Stoughton , MA; wd l :20); (v) mouse mono-
clonal anti-chicken cellular fibronectin (Sigma Immuno 
Chemicals; wd 1 :400) which reacts with most species; 
(vi) affinity purified rabbit polyclonal anti-rat Type I 
collagen (Biodesign International , Kennebunk, ME; wd 
1: 100). 
Secondary FITC (Fl uorescein isothiocyanate)-con-
j ugated antibodies (Jackson Immunoresearch Laborato-
ries, Inc. ; wd 1 :50) for fluorescence microscopy while 
secondary 20 nm and 30 nm colloidal gold-conjugated 
antibodies (Biocell Research Laboratories, wd: 1 :20) 
were used for scanning electron microscopy (SEM). 
Microdissection of cultures 
In order to facilitate access , by the antibodies 
employed, to the extracellular matrix at the culture sub-
stratum, it was necessary to undertake a simple micro-
dissection procedure following fixation. Briefly , the tis-
sue culture dishes were viewed with a dissecting micro-
scope (Wild M3) and areas of greater cell density, which 
represented the easily discernable developing bone nod-
ules , were identified . Using a scalpel (number 11 blade) 
parallel lines, approximately 2 mm apart, were cut from 
the centre to the periphery of a nodule and into the sur-
rounding extra-nodular cell layer. A perpendicular inci-
sion was then made to transect these parallel cuts in the 
central portion of the nodule. Using the tip of the scal-
pel blade and fine forceps, a flap of cells and tissue was 
raised from the central area of the nodule which extend-
ed beyond the periphery of the nodule, and detached 
from the remaining tissue in the culture dish. Several 
flaps were created in any one culture dish to allow 
labeling of multiple developing bone nodules . 
Fluorescence microscopy 
The cells cultured on coverslips were fixed with 
4 % paraformaldehyde and 0.1 % glutaraldehyde in PBS 
for 1 hour , then incubated with primary antibody for 30 
minutes at room temperature, washed in PBS and incu-
bated again with secondary FITC-conjugated antibody. 
The cells were washed again with PBS before being 
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mounted with anti-bleach medium. Controls for labeling 
specificity included omission of the primary antibody, 
normal serum, collagen Type II and pre-saturated prima-
ry antibody with correlated antigen. The cultures were 
then observed in Leitz microscope equipped with a 
selective filter for fluorescein. 
Scanning electron microscopy 
The immunogold labeling method for SEM was 
adapted from the procedure described by de Harven et 
al. (1984). Following rinsing in a-MEM and PBS , first 
passage subcultured rat bone marrow cells were prefixed 
in 4% paraformaldehyde in PBS, pH 7.4, for 30 minutes 
at 4 °C and then washed with 0.1 % glycine in PBS to 
quench free aldehyde groups. The cell multilayer was 
retracted, as described above, to expose the interface 
structure and facilitate antibody access to the interfacial 
extracellular matrix. To reduce non-specific labeling , 
the cells were placed in 5 % normal serum (from the 
same species as the host used to raise the secondary con-
jugated antibody) in 0.5 % bovine serum albumin/PBS 
for approximately 30 minutes. After this, they were in-
cubated with the primary antibody overnight at 4 °C fol-
lowing which a further incubation was carried out, for 
2 hours at room temperature, with 20 or 30 nm second-
ary gold-conjugated antibody. After thorough rinsing in 
PBS, the cells were post-fixed in 2.5 % glutaraldehyde in 
0.1 M phosphate buffer for 2 hours at 4 °C. Ethanol de-
hydration was followed by critical point drying from 
C02 and mounting on aluminum stubs. The preparations 
were coated with evaporated carbon to facilitate detec-
tion of the gold particles by backscatter electron imaging 
(BSEI) . Specimens were observed with an Hitachi S-570 
scanning electron microscope, operated at 20 kV, in both 
the secondary electron imaging (SEI) and BSEI modes. 
Photomicrographs were recorded on Polaroid PIN 55 
film . 
Results 
Initial attempts to label the components of the ex-
tracellular matrix at the interface with the underlying 
culture substratum failed due to lack of penetration of 
primary antibody through the dense surface cell layers. 
To circumvent this problem, the microdissection proce-
dure, described above, was employed. An example of 
the result of the dissection procedure is seen in Figure 
l. While damaging the tissue in this way clearly ex-
posed the underlying interfacial matrix, it also led to the 
scratching of the culture dish surface. We refer to such 
scratches in the description of several figures below, 
since these provided convenient markers of the culture 
substratum surface and therefore, the level of the inter-
face. In older cultures, the removal of the cell layer 
allowed clear visualization of the globular interfacial 
matrix as illustrated in Figure 2. 
It should be noted that while the cultures exam-
ined varied in age from 3 to 11 days, these were not 
monolayer cultures. As described in the original report 
by Maniatopoulos et al. (1988), the cells start to multi-
layer, prior to reaching confluence, as a prelude to bone 
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Figure 1. Low magnification scanning electron micro-
graph to illustrate the microdissection of a rat bone 
marrow cell culture. The multilayered geometry is 
clearly seen as are the scratch marks in the interfacial 
tissue which have exposed the underlying culture dish 
surface. Field Width [FW] = 1.04 mm. 
Figure 2. The cell layer has been removed from part of 
this culture to reveal the underlying globular interfacial 
matrix (arrows). FW = 104 µm. 
nodule formation. Thus, a cell nodule exists before dis-
cernable mineralized matrix production and, as the nod-
ule develops , the periphery of a nodule represents a less 
mature region than the central area. Each developing 
bone nodule therefore represents a time-capsule of de-
velopment and an eight-day culture, for example, will 
contain nodules which comprise central regions which 
represent eight days of development while other , more 
peripheral , regions of the same nodule are representative 
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Figure 3 (above). Immuno-SEM of CS-56 at an early 
culture stage. (A) Secondary electron image (SEI) and 
(B) backscatte.red electron image (BSEI) of the same 
field of view. FW = 6 µm. 
Figure 4 (at right). Immuno-SEM of CS-56 at a later 
culture stage. (A) SEI [bottom] shows collagen fibres 
overlying the previously formed globular accretions. 
The BSEI [top] clearly demonstrates the presence of the 
label , but no association with the collagen fibres is 
apparent. (B) SEI [bottom] and BSEI [top] of a control 
sample incubated without the primary antibody. The 
parallel sided dark band running vertically through the 
field of view is a scratch mark (S) exposing the underly-
ing culture substratum. (C) FITC image of CS-56 la-
beled sample showing ubiquitous distribution of this 
antibody. Note: the punctate appearance of the label on 
the culture substratum (*) as well as the cell labeling 
(c). FW = 6 µm (A, B); 225 µm (C). 
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Figure 5. Osteopontin signals at two developmental stages of this culture system. (A) At an early stage the label is 
strongly expressed at the ends of cell pseudopods associated with attachment to the underlying substratum. At a later 
stage (B) the substratum itself is strongly labeled together with the periphery of the cell membrane. Note: 1) the linear 
striations in the substratum label indicative of re-distribution of the protein as a result of change in cell shape in (B); 
and 2) the strong signal from the nuclear area of the cell (N) is due to autofluorescence resulting from the glutaralde-
hyde fixation. These black and white images were reproduced from original Ektachrome 400 colour slides. FW = 
225 µm (A); 140 µm (B). 
Figure 6. Osteopontin visualized at an early development stage in culture is associated with sub-micrometer fragments 
of extracellular matrix which are clearly seen (A) in the SEI. The immuno-gold conjugate of the same area seen in 
BSEI mode (B) is congruent with the matrix seen in (A). FW = 6 µm. 
of the least mature stages of development. For this 
reason, the majority of observations we make herein are 
referred to as originating from less or more mature 
developmental stages rather than quoting the age of the 
culture in days. 
In all cases, the antibodies employed demonstrat-
ed reproducible differences between experimental, nega-
tive and positive control specimens although the intensity 
of fluorescence or density of gold labeling varied within 
each sample group as a function of the site within a 
particular culture being viewed and the morphology of 
the attendant tissue. 
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Chondroitin sulphate was observed at the earliest 
time periods in this culture system and displayed a ubiq-
uitous distribution both on the culture substratum and 
within the multilayered cell nodules. Figures 3A and 3B 
show the secondary and backscattered images of deposits 
on the culture substratum which are labeled with CS-56. 
At later time periods, CS-56 was still detectable (Fig. 
4A); again the distribution was random without obvious 
association with collagen fibres (Fig. 4A). A control 
sample, without the primary antibody clearly demon-
strated the specificity of the label (Fig. 4B). The 
immunofluorescent staining for CS-56 was observed 
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from 3 days primary culture. The fluorescence exhibited 
a fine dotted pattern both on the substratum and over the 
cell surface with an increased density along the margin 
of cells as shown in Figure 4C. 
The distribution of osteopontin was quite different 
as visualized using the FITC-conjugated antibody . At 
early culture stages the label was demonstrated predomi-
nantly at the ends of cell pseudopodia which were clear-
ly associated with areas of attachment to the underlying 
substratum (Fig. 5A). With increasing culture maturity, 
this distribution changed significantly to exhibit strong 
immuno-labeling on the substratum surface as well as the 
cell periphery. Also, the distribution on the substratum 
surface was marked by linear areas which appeared de-
void of label. These linear patterns were directed to-
wards the individual fimbriae of the neighbouring cell as 
illustrated in Figure 5B. Immuno-SEM revealed that os-
teopontin was, indeed , detectable at the culture surface 
at very early stages of extracellular matrix development 
(Fig. 6). 
The other major adhesion protein assayed was cel-
lular fibronectin which showed a distribution quite dif-
ferent to that of osteopontin. In less mature cultures, 
the label was visible only in direct association with 
cells, as shown in Figure 7A. While no apparent signal 
was detected on the substratum surface , it was not possi-
ble to judge if the cell-related label was internal or ex-
ternal to the cell membrane. Nevertheless, labeling was 
prominent at points of cell attachment, associated with 
the classical appearance of intracellular filaments , which 
suggested some involvement in attachment mechanisms. 
This became clearer with the maturity of the culture 
where the cellular fibronectin antibody labeled inter-cel-
lularly , possibly in association with some extracellular 
matrix (Figure 7B). In the spaces between cells there 
was, again, no evidence of labeling on the substratum 
surface as had been so easily seen in the case of osteo-
pontin. The association of this label with extracellular 
matrix was more clearly seen by immuno-SEM. Figures 
8A and 8B show the SEI and BSEI of a more mature 
culture with an evident and abundant extracellular fibre 
matrix. Here, the fibronectin label was specifically 
associated with this fibre compartment. 
No evidence of the presence of Type I collagen in 
the extracellular matrix was found at early periods of 
culture, although intracellular labeling was positive (Fig. 
9A). Only in more mature cultures, following the for-
mation of the initial cement-like matrix, was Type I col-
lagen evident as assembled fibres (Fig. 9B) which label-
ed specifically as illustrated in Figures lOA to lOF. 
Even in samples demonstrating the specificity of the 
Type I antibody employed (Figs. lOB, lOD) no evidence 
was seen of labeling of the underlying calcified accre-
tions of the cement line matrix. However, Type III 
collagen displayed the inverse sequence. In less mature 
cultures, it exhibited a ubiquitous distribution, somewhat 
similar to chondroitin sulphate (Fig. 11), while it was 
undetectable at later stages of culture. Immuno-SEM 
demonstrated the apparent association of the Type III 
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antibody with the fibrous extracellular matrix of mature 
cultures , although the specificity of labeling ~ as seen 
with Type I collagen, was absent (Figs. 12A and 12B). 
Finally, osteocalcin was the only antibody em-
ployed which showed no labeling at early culture periods 
while at later stages both the cellular compartment and 
the previously formed interfacial matrix labeled positive-
ly . Indeed, using the fluorescently labeled antibody, the 
labeling clearly demarcated scratches in the interfacial 
layer caused by sample preparation, in a similar manner 
described for osteopontin (Fig. 13A) . Immuno-SEM 
confirmed the attachment of the label to the previously 
formed calcified accretions (Figs. 13B and 13C). 
Discussion 
The purpose of the experiments reported herein 
was to characterize the initial, interfacial, extracellular 
matrix laid down by the differentiating osteogenic cells 
in our culture system . We know from the original de-
scription (Maniatopoulos et al. , 1988) that this culture 
system will produce a high yield of bone nodules that ex-
hibit morphological, ultrastructural and biochemical 
characteristics of bone tissue. Specifically, 
Maniatopoulos et al. (1988) demonstrated that the miner-
alized , calcium hydroxyapatite , extracellular matrix of 
such nodules comprised collagen (predominantl y type I, 
although type III was also detectable), osteonectin and 
osteocalcin. We have also shown, in previous studies, 
that the cells at the substratum surface will produce an 
organic matrix, apparently free of assembled collagen fi-
brils, which becomes seeded with small crystallites to 
form globular accretions approximately 1 µrn in diameter 
and approximately 0.5 µm in height (Davies et al., 
1991 a). Fusion of these globules on the culture surface 
creates a linear calcified layer which separates t e devel-
oping bone nodule from the underlying substra um. We 
have compared this initial extracellular matrix with the 
cement line found in natural bone tissue and have shown 
the structural similarities of this early in vitro matrix 
with extracellular matrix elaborated at reversal lines in 
both mature and immature bone. The purpose of the 
work reported herein was twofold: first, to identify the 
presence of bone specific organic components in the ear-
ly interfacial matrix which could be implicated in pro-
viding seeding sites for calcium phosphate crystals; and 
second, to confirm, using immunohistochemistry, our 
lack of morphological evidence of a collagen component 
to this early matrix. 
Initial characterization of the earliest organic ma-
trix secreted by the differentiating osteogenic cells in 
our culture system has been achieved using fluorescent 
or gold labeled antibodies to six known matrix compo-
nents . Clearly, even a comprehensive approach includ-
ing a large number of specific and non-specific bone 
proteins could exclude proteins which may play impor-
tant roles in these early matrix assembly events but 
which have not yet been identified . However, our initial 
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Figure 7. Cellular fibronectin visualized at an early stage (A) and more mature stage (B) of culture . At neither stage 
was there labeling of the culture substratum as noted for osteopontin . While there is early evidence of label at sites 
of focal contacts (arrowheads), as the culture developed , it became evident that the fibronectin was associated with a 
fibrillar extracellular compartment. FW = 225 µ.m (A , B). 
Figure 8. Immuno-SEM of cellular fibronectin: (A) SEI and (B) BSEI. The antibody label is clearly associated with 
the fibrillar extracellular compartment. FW = 15 µ.m. 
Figure 9. Labeling for Type I collagen at early (A) and later (B) stages of culture. Note that in (A) , only an 
intracellular signal is seen. FW = 225 µ.m (A , B). 
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studies have yielded interesting results which correlate 
both with our previous morphological observations and 
other reports in the literature concerning expression of 
osteoblast phenotype related gene products. We have 
shown temporal changes in interfacial protein synthesis. 
Fibronectin , collagen type III and osteopontin were all 
present at the interface before collagen type I, although 
the latter was expressed by cells at early time points, 
while osteocalcin was only seen in the later stages of 
culture. These differences were consistent between the 
two techniques used. 
The secretion of an organic matrix prior to calci-
fication is to be expected since this forms the basis of all 
biomineralization systems where macromolecules con-
taining acidic groups, sulphates, carboxylic acids or 
phosphates may be involved (Alper, 1992). The roles of 
non-collagenous bone proteins have been thoroughly re-
viewed, in the implant context, by Sodek et al. (1991). 
Of these osteopontin, which is highly sulphated , de-
serves special attention as it is implicated, by the pres-
ence of an arginine-glycine-aspartic acid (RGD) se-
quence, in osteoblast attachment (Oldberg et al., 1986; 
Sommerman et al., 1987; Butler, 1989) as well as 
hydroxyapatite nucleation and could thus serve both 
functions at the interface. 
The presence of osteopontin was expected based 
on its localization at cement lines in vivo (McKee et al. , 
1992 , 1993 ; Chen et al. , 1993) , and that studies on the 
developmental appearance of osteopontin have demon-
strated that 'preosteoblasts', as well as osteoblasts and 
osteocytes , expressed osteopontin mRNA (Nomura et 
al. , 1988, Weinreb et al., 1990) and were strongly 
stained immunohistochemically (Mark et al., 1987). 
This would appear to contradict the results Ibaraki et al. 
(1992) who reported that in vitro osteopontin levels were 
initially low, and increased coordinately with the expres-
sion of type I collagen and alkaline phosphatase, and 
those of Yoon et al. (1987) who reported that in vivo os-
teopontin expression occurs late, after collagen I and al-
kaline phosphatase but coordinately with osteocalcin, 
which suggests that osteopontin expression occurs only 
in fully differentiated osteoblasts. This difference may 
be explained by the results of Owen et al. (1990, 1991) 
and Strauss et al. (1990) who reported that there was an 
initial peak of osteopontin mRNA levels early in culture 
which declined and was followed by a second peak as the 
cultures began to mineralize. Indeed, Owen et al. 
(1990) observed that osteopontin gene expression peaked 
at 25 % maximal levels on day 7 , was no longer detect-
able on days 10 and 12 , and finally reached maximal 
levels on day 20 in rat fetal calvarial cultures. It has 
been suggested that the initial induction of osteopontin 
may be involved in controlling the relationships between 
cells and extracellular matrices (Lian and Stein , 1992). 
It was therefore not surprising that osteopontin was lo-
calized at the ends of cell pseudopodia at early culture 
stages, implying a role in cell attachment, and strongly 
expressed on the substratum surface where calcification 
ensued to produce the cement-like globular layer. 
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Figure 10 (on the facing page). SEI (A, C and E) and 
the corresponding BSEI (B, D and F) of Type I Colla-
gen . In (A) , bundles of collagen fibres are seen running 
vertically on the right of the field of view. Little can be 
discerned of the underlying calcified globular accretions 
(Ca) which are seen more easily in the BSEI in (B). The 
colloidal gold marker is only seen in the collagen fibre 
containing compartment. The specificity of the antibody 
to these fibres is illustrated in higher magnifications of 
a similar field of view (C , D). Control specimens , with-
out the primary antibody are shown in (E) and (F). FW 
= 6 µm (A , B, E, F); 3 µm (C , D). 
Owen and co-workers (Owen et al., 1990 , 1991 ; 
Barone et al., 1991 ; Lian and Stein, 1992) have exam-
ined the expression of several matrix proteins in vitro. 
Fibronectin mRNA levels are initially high and decline 
throughout the culture period , osteopontin as already 
discussed peaks early , declines and then rises to its 
maximal level. Type I collagen mRNA rapidly reaches 
its maximal level and then declines . Osteocalcin levels 
are undetected until late in culture at which point they 
rapidly increase to maximal levels. Although type I 
collagen mRNA levels were initially 50% maximal and 
reached maximal levels by day 10 of culture type I colla-
gen did not begin to accumulate in the cell/matri x layer 
until after the mRN A levels were declining (Gerstenfeld 
et al ., 1988; Barone et al. , 1991) . Examination of col-
lagen secretion and accumulation into the matrix of 
chick osteoblast cultures revealed that al though collagen 
was being synthesized and secreted into the medium 
from the earliest time point examined (day 3), collagen 
accumulation into the matrix was initially negligible, 
rapidly increasing between days 6 and 12 (Gerstenfeld et 
al. , 1988). This was thought to occur due to incomplete 
processing of the procollagen molecules in the early 
stages of culture. Our results are not only in agreement 
with these reports , but also corroborate the absence of 
assembled collagen in the interfacial matrix in vitro 
(Davies et al., 1991b) as well as at bone implant inter-
faces (Davies et al., 1991a,c; Pilliar et al., 1991) and 
cement lines in vivo (Zhou et al., 1993). 
The early intercellular matrix was rich in fibro-
nectin, as were focal contacts, although no fibronectin 
was observed at the substratum interface. Similar re-
sults were obtained by Gronowicz and DeRome (1992) 
who examined the differential expression of fibronectin, 
osteonectin and collagen I during calvarial de elopment. 
Utilizing northern blot analysis , in situ hybridization and 
immunofluorescence , they demonstrated that fibronectin 
synthesis preceded type I collagen expression and was 
predominantly seen around the condensed preosteoblasts. 
Majmudar et al. (1991) demonstrated that he matrix 
synthesized by chick osteoblasts in vivo and in vitro con-
tained fibronectin and type III collagen as well as type 
I collagen. It is known that one adsorbed protein species 
can be replaced by another of higher affinity for a 
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surface (Norde, 1986). Thus, it is possible that fibro-
nectin was competitively replaced by osteopontin at the 
substratum surface. 
Numerous studies have reported that bone cells in 
vitro synthesize collagen type III as well as type I 
(Maniatopoulos et al., 1988; Wranna et al., 1988; Collin 
et al., 1992) although it was not clear whether this was 
synthesized by osteogenic cells or by contaminating fi-
broblasts. Multimaki et al. (1987) examined collagen 
gene expression during endochondral fracture repair and 
demonstrated that, during the first week, type III colla-
gen mRNA increased to the greatest extent which was 
correlated with the development of granulation tissue 
and primitive mesenchymal callus. By 28 days, the pre-
dominant collagen mRNA was type I with very little type 
II or III. Collagen type III has also been identified in 
mesenchymal condensations prior to endochondral ossifi-
cation (Reddi et al., 1977; Lane et al., 1986; Page et 
al., 1986) and recently has been identified in intramem-
branous bone (Carter et al., 1991; Majmudar et al., 
1991). These results suggest that type III collagen is ex-
pressed during the initial stages of osteogenesis. We 
have observed that type III collagen is present in the 
early extracellular matrix and that as the culture ma-
tures, collagen III becomes undetectable. 
We observed that osteocalcin did not appear in the 
early cultures, but was seen at later stages, being asso-
ciated with both the cellular compartment and the previ-
ously formed calcified accretions of the cement line-like 
layer. This observation would suggest that while osteo-
calcin was not synthesized during the formation of the 
cement like matrix, this bone specific protein, once se-
creted, did attach to the underlying mineralized matrix. 
Our results agree with previous studies on the expression 
of osteocalcin which have invariably demonstrated that 
it is not expressed until late in the developmental cas-
cade (Bronkers et al., 1987; Yoon et al., 1987; Owen et 
al., 1990, 1991; Strauss et al., 1990; Weinreb et al., 
1990). Recently there have been reports that osteocalcin 
was localized at reversal lines (McKee et al., 1992, 
Carlson et al., 1993). This does not necessarily mean 
that osteocalcin was synthesized as the cells elaborated 
the cement line matrix. Osteocalcin is present in serum 
and rapidly accumulates in mineralized tissues due to its 
high affinity for hydroxyapatite (Hauschka et al., 1989). 
Delmas et al. (1984) demonstrated that bone contains 
many serum proteins which are not derived from osteo-
genic cells. This suggests that osteocalcin found at re-
versal lines could derive from neighbouring osteoblasts 
which were in the process of synthesizing and secreting 
matrix, including osteocalcin, or could have been re-
leased into the extracellular fluid from bone matrix dur-
ing resorption. A similar process may be occurring in 
our model system where osteocalcin appears at both the 
interface and in the intercellular compartment. After 
matrix mineralization is initiated, mature osteoblasts, 
present in the culture, would be synthesizing and secret-
ing osteocalcin which could adsorb to any available min-
eralized matrix. 
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Figure 11. Immuno-fluorescence of Type III collagen 
at an early culture stage demonstrates the ubiquitous 
distribution of this protein. FW = 225 µm. 
Figure 12. Immuno gold labeling of Type III collagen 
(A) SEI and (B) BSEI, shows preferential distribution in 
the fibrous extracellular matrix rather than the cell 
surface. FW = 6 µm (A, B). 
Figure 13. (A) Immuno-fluorescence of anti-osteocalcin 
antibody at a more mature culture stage. No signal for 
this protein was detected in early cultures. Neverthe-
less, the calcified interfacial extracellular matrix is 
strongly positive and illustrates scratch marks (s) on the 
substratum surface. (B) SEI and (C) BSEI of calcified 
accretions. Note that each gold particle is associated 
with an accretion rather than the underlying culture 
substratum. FW = 225 µm (A); 6 µm (B, C). 
One question which must be addressed is: Does an 
in vitro assay bear any relevance to in vivo reality? This 
is especially important in the context of modeling bone/ 
implant interfaces in view of the expressed belief that 
such experiments "reflect the assumed reality of the test 
tube" (Albrektsson, 1992). This issue has been ad-
dressed previously (Davies, 1990), and we have also 
published experimental evidence which indicates the sim-
ilarity of the morphological appearance of the cement 
line-like extracellular matrix, at retrieved implant sur-
faces, to that which we have described for the first time 
in culture (Davies et al., 199la,b,c). However, the ce-
ment line structure is not always recognized from in vivo 
studies. Some confusion has arisen with the linking of 
this morphological descriptor with the term lamina limi-
tans both in the bone and implant literature (McKee et 
al., 1993; Davies, 1991). The lamina limitans is a fea-
ture produced in demineralized sections only , and rep-
resents a concentration of proteins which is not visual-
ized in sections which are un-decalcified, while cement 
lines are distinct, and normal, morphological structures 
in bone. 
Finally, the change in cell shape, evidence for 
wh\ch we have now observed in both scanning electron 
microscopy (Davies et al., 1991 b) and the osteopontin 
labeling at the substratum surface illustrated herein, is 
worthy of note. Cell morphology is maintained by the 
cytoskeleton, and the latter is linked to intranuclear fila-
ments. Thus, the cytoskeleton and associated changes in 
cell shape are implicated in important cell functional 
roles (Fey et al., 1984), since it is through this fibre 
network continuum that gene regulation by extracellular 
agents has been hypothesized (Ben-Ze'ev, 1991). Thus, 
observations of change in shape of the differentiating os-
teogenic cells in our culture system may well be related 
to changes in gene expression linked to the continued 
differentiation of these cells. The correlative light and 
scanning electron microscopy demonstrated similar cell 
morphology on coverslip glass and tissue culture poly-
styrene. However, from the perspective of bone cell/ 
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biomaterial interactions, the observations that bone-de-
rived cells can adopt different morphological appear-
ances on substrata of different chemical (Davies et al., 
1986) or physical (Bowers et al., 1992) properties may 
have important implications in bone formation on can-
didate implant materials. 
Conclusions 
The experimental approach described has been 
employed to deconvolute the temporal sequence of 
events which characterize organic matrix secretion by 
differentiating osteogenic cells at the surface of a culture 
substratum. In particular , the presence of osteopontin 
implies a dual role for this protein in both cell attach-
ment and mineralization of an organic matrix which is 
devoid of assembled type I collagen fibres and, we con-
sider, reflects the structure and composition of cement 
lines found at remodeling sites in bone. The appearance 
of both type I collagen and osteocalcin at later develop-
mental stages in culture not only agrees with previously 
published data, but also indicates that the cement line-
like matrix is elaborated, and mineralized before these 
osteogenic cells express their mature, osteoblastic 
phenotype. 
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Discussion with Reviewers 
M.D. McKee: Could you elaborate on what you consid-
er to be the distinction between cement lines and laminae 
limitantes in the context of bone remodeling? 
Authors: As has been discussed in detail elsewhere (see 
index entries in Davies, 1991), cement lines are distinct 
morphological features of normal bone which are seen at 
specific sites (e.g., the outer margins of Haversian sys-
tems), whereas laminae limitantes are features only ob-
servable in decalcified sections. A useful analogy may 
be drawn here with the basophilia associated with many 
linear structures in bone, resting and reversal lines, 
interlamellar lines etc. Such common staining patterns 
indicate some common compositional features of many 
structures, which depend on the use of decalcified speci-
mens (a true complication when interpreting hard tis-
sues), but are not themselves structural markers. This 
is important since, on the one hand staining bands (sic. 
laminae limitantes) may occur at diverse sites in tissue 
which (in the normal state) may be either calcified or not 
calcified while, the linear structures stained may be of 
widely different thicknesses and, perhaps, represent 
en ti rely disparate functional roles. 
Thus, the term lamina limitans can be applied to 
any linear structure which separates one area, or type, 
of tissue from another, e.g., the relatively broad elec-
tron dense borders of variable width which can be seen 
in decalcified sections of focal areas of mineralization in 
bone, or the fine linear arrangements seen on the walls 
of osteocyte canaliculi. Such staining reactions, may be 
as generalized as basophilia itself, or within one tissue 
may be due to the presence of similar groups of proteins 
at various sites within, for example, bone matrix. On 
the other hand cement lines which share both the baso-
philia and non-collagenous bone protein composition 
with other linear features in bone are structurally quite 
distinct. Unlike the lamina limitans of the osteocyte ca-
naliculus, which is of the order of 2 nm wide and (prob-
ably) not mineralized, the cement line is about 500 nm 
wide and of the same mineral composition as neighbour-
ing bone although of relatively greater density due to the 
absence of assembled collagen fibres. While the osteo-
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cyte canaliculus marks the limit of a hard tissue mass, 
the cement line forms the interface between old and new 
bone tissue. No other linear basophilic structure in bone 
is of this dimension. Interlamellar lines, while basophil-
ic and marking the junction between older and newer 
bone, do not represent the discontinuum of the collagen 
containing bony compartment seen at cement lines but 
simply a change in direction of collagen fibres produced 
by the same population of osteogenic cells. 
Thus, in terms of remodeling, cement lines are 
the morphologically distinct boundary tissue which pro-
vides the interface between old (resorbed) bone and new 
bone being laid down by the new population of osteogen-
ic cells which occupy the resorption site. Since cement 
lines contain bone-associated proteins such as osteopon-
tin and bone sialoprotein and appear at a time when the 
osteogenic cell population, which will form the first 
bone lamella, is differentiating, we believe that the ce-
ment line represents the earliest bone matrix produced 
by differentiating bone cells and is thus of central im-
portance in the remodeling cascade. We believe that our 
in vitro results, reported and cited herein, attest to this 
interpretation of the relevance of cement lines. 
H. Lesot: What is known about the molecular composi-
tion of cement and what is involved in the mineralization 
of this specific matrix? 
J.-R. Nefussi: It is not clear what the authors mean by 
cement like matrix in vitro. Is it (1) the first material 
synthesized by a bone cell during its attachment and 
spreading, or (2) the first deposit preceding the matrix 
bone formation, or (3) both of them. Knowing that all 
bone cells attached to a surface will not express a bone 
matrix until a three dimensional environment is formed 
(as accepted by most of the authors in the literature, 
ourselves included, Nefussi et al., 1985). We do not 
believe in the first and third hypothesis. Therefore, 
results concerning the very early times where no nodules 
have yet been formed are, in that respect, questionable. 
Authors: Comparatively little is known about either the 
composition or mineralization of cement lines . We have 
recently provided a review of the available literature in 
Zhou et al. (1993). What is becoming clear from both 
our work (Davies et al., 1991 b) and that of McKee et al. 
(1992, 1993) is that the cement line comprises an organ-
ic matrix, devoid of assembled collagen fibres (confirm-
ing the original histological work of Weidenreich, 1930) 
but rich in other proteins characteristic of bone matrix. 
Even less is specifically known about the mechanisms of 
mineralization of this matrix, although both osteopontin 
and bone sialoprotein have been implicated in providing 
seeding sites for calcium phosphate crystal nucleation 
(Butler, 1989; Sodek et al., 1991). However evidence 
from Goldberg et al. (1993) have implicated only BSP in 
this role. With regard to the cement like matrix in vitro, 
we have described this in detail elsewhere (Davies et al., 
1991a, b) and believe it to be an integral , although mor-
phologically distinct, part of normal bone extracellular 
matrix; just as is the case in vivo. 
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H. Lesot: How does the appearance-disappearance of 
antigens occur when following the immuno-staining from 
the periphery to the center of individual nodules? Are 
there overlapping zones? Are there specific areas where 
cells transitorily co-express antigens? 
Authors: The first point to make is that as the center of 
individual nodules is approached, the extracellular ma-
trix, both at the interface and within the bulk of the 
nodule, calcifies. This, as is well known in hard tissue 
biology, compromises the penetration of antibodies and 
also blocks binding sites which would have been avail-
able before mineralization. For this reason, we have not 
said collagen III disappears but rather that it is undetect-
able. Nevertheless, in the maturation of enamel matrix, 
it is now believed that proteins are specifically removed 
from the matrix by ameloblasts. Thus, there may be a 
possibility that analogous behaviour may be found in 
osteoblasts. 
H. Lesot: According Fig. 4C, one might expect chon-
droitin sulphate to be closely associated with focal con-
tacts; is this true when using scanning electron micros-
copy? Is there a correlation between the two techniques 
as far as antigens potentially involved in the formation 
of the focal contacts are concerned? 
Authors: It is not possible , with the SEM technique 
which we have employed, to visualize the molecules in-
volved in cell membrane binding at focal contacts, and 
we are thus unable to address this question. 
H. Lesot : It has been reported that use of intact immu-
noglobulins instead of Fab fragments could lead to nega-
tive results because of steric problems. Could the 
authors comment on this point based to their experience? 
Authors: We have no experience with the use of Fab 
fragments in this specific experiment. However, since 
we exposed the substratum surface by stripping away the 
overlying cell layers, we do not believe that our results 
would be compromised by the lack of penetration of im-
munoglobulins which , in intact tissue, can lead to false 
negative results. 
H. Lesot: If osteopontin does play a specific role in 
controlling the relationships between cells and extra-
cellular matrices in this precise case, does it mean that 
osteopontin has functions essentially different from fi-
bronectin (i.e., in the mediation of matrix-matrix inter-
actions) which would also be a good candidate for such 
a function or does it mean that differential expression of 
integrins might indeed play a key role? 
Authors: Although we do not know the functions of 
these proteins, it has been observed that cell attachment 
and spreading persists on osteopontin coated substrata 
while it is only transitory on fibronectin coated substrata 
(Sauk et al., 1991). This along with the observation that 
osteopontin expression is differs from that of fibronectin 
(Owen et al. 1990; Stein et al. 1990) would suggest that 
they have different functions in osteogenesis. We have 
no information concerning the expression of integrins in 
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our model system. From the literature (Sauk et al., 
1991) it is evident that fibronectin binds to a variety of 
different integrins, including two which are specific for 
fibronectin. Osteopontin is thought to bind to the 3.y{33 
receptor, which itself binds several other matrix pro-
teins, including fibronectin. Thus, it is possible that 
differential expression of these integrins plays a role in 
the interaction between the cells and the matrix. 
H. Lesot: Is it known whether the replacement of fibro-
nectin by osteopontin is accompanied qualitative changes 
in the expression of integrins? 
Authors: No, we are suggesting replacement of fibro-
nectin by osteopontin may happen but have no experi-
mental data to propose this idea as an hypothesis. 
J .-R. Nefussi: The authors should not exclude to indi-
cate the time of the observations reported when pictures 
are related to early time points (before nodule forma-
tion). This will avoid any confusion as the absence of 
collagen fibers at early periods of culture which is 
normal before 24 hours but which would be surprising 
after. 
Authors: We discuss, in some detail, why we believe it 
is misleading to attach specific temporal values to our 
cultures. However, we should perhaps emphasize that 
the earliest cultures were 3 days and therefore, we are 
not in a position to comment on pre-24 hour cultures. 
J .-R. Nefussi: How do the authors explain detectable 
osteopontin protein "at very early stages" at areas where 
no cells are present as mentioned in the Results? Where 
is this protein coming from? 
Authors: The protein is coming from cells which have 
been removed to expose the underlying culture surface. 
R.M. Albrecht: Have isotype controls been performed 
to insure that nonspecific binding of the primary mono-
clonal antibody is also minimal? 
Authors: Yes, we performed such controls for the fluo-
rescence labelling and found no signal detectable other 
than the autofluorescence due to glutaraldehyde fixation. 
We did not perform equivalent controls for the immuno-
SEM. 
R.M. Albrecht: In some instances, the level of gold 
label seems to be in line with the extent of deposition of 
the antigenic species (Fig. 6 for example). In other in-
stances the level of label appears to be less dense (Fig. 
3 or 4). Does this reflect a reduced number of antigenic 
species or a reduced efficiency of labeling? 
Authors: Given the extent of both matrix and labelling 
in Figures 3 and 6, we feel that it would be unreasonable 
to state that these images represent significant differ-
ences in either the number of antigenic species or the 
labeling efficiency. In the case of Fig. 4, a later stage 
of culture in which calcification of the interfacial matrix 
is already clearly evident, the apparent reduction in 
labeling could be due to either an absolute reduction of 
X. Shen, E. Roberts, S.A.F. Peel and J.E. Davies 
antigenic species, or a masking of the latter due to the 
mineralization. 
R.M. Albrecht: Have the authors seen any significant 
differences in the patterns of deposition and sequence of 
deposition on the different substrates they have used to 
date? 
Authors: Yes, we have seen considerable differences in 
patterns of deposition on modified polystyrene surfaces 
(Peel et al. 1992, Callen et al., 1993), but have not yet 
compared this morphological information with the immu-
no-labeling which we report herein. 
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